Market revenue in 2023 | USD 606.5 million |
Market revenue in 2030 | USD 1,459.4 million |
Growth rate | 13.4% (CAGR from 2023 to 2030) |
Largest segment | Hydrogels |
Fastest growing segment | Micropatterned Surface Microplates |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Tecan Group AG, Becton Dickinson & Co, Medtronic PLC, Matricelf Ltd, Corning Inc, Avacta Group PLC, Vericel Corp, NuVasive, Allergan, ReproCELL, 3D Biotek, Xanofi, Molecular Matrix, Pelo Biotech, Azenta Life Sciences, Akron Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to scaffold technology market will help companies and investors design strategic landscapes.
Hydrogels was the largest segment with a revenue share of 41.58% in 2023. Horizon Databook has segmented the Europe scaffold technology market based on hydrogels, polymeric scaffolds, micropatterned surface microplates, nanofiber based scaffolds covering the revenue growth of each sub-segment from 2018 to 2030.
Broadening scope of 3D cell culture applications in various fields of research, such as stem cells, cancer biology, and tissue engineering, has led biologists to adopt 3D cellular models that involve scaffold technology.
Furthermore, collaborations among market entities have contributed heavily to the region’s significant market share. For instance, in November 2013, Reinnervate Ltd., a UK-based company, entered into a partnership with Oncotest GmbH for further development of 3D cell culture technology, which is expected to boost segment growth over the forecast period.
The opening of new headquarters in Glasgow by REPROCELL in August 2017 expanded the company’s drug discovery services and translational research in Europe. Similar initiatives are expected to improve 3D cell culture applications and translational research applications in Europe, consequently increasing utilization of scaffold technology.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe scaffold technology market , including forecasts for subscribers. This continent databook contains high-level insights into Europe scaffold technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account